Michael R Hand, MD
Nephrology · Monroe
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 35 years
- Tulane University School of Medicine, 1991
Offices
1 location · Northeast Louisiana Kidney Specialists,LLC · 8 clinicians in this group
Hospitals listed: 192510 · 192627 · 192676 · 192701 · 192712 · Fmol Health St Francis · Franklin Medical Center · Glenwood Regional Medical Center · Morehouse General Hospital · Union General Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Hand’s office at (318) 323-8847 to ask if they take your plan before you enroll.
Hospitals they work in
5 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Fmol Health St FrancisMonroe, LAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Franciscan Missionaries of Our Lady Health System, which runs 11 hospitals in 2 statesPatients rate it 4 of 5 · 76% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.498, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.423, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.25, Oct 2024 – Sep 2025
- Franklin Medical CenterWinnsboro, LAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department79% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
- Glenwood Regional Medical CenterWest Monroe, LAAcute Care Hospital · Proprietary · Has an emergency departmentPart of Steward Health Care System, which runs 36 hospitals in 8 statesPatients rate it 4 of 5 · 75% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.062, Oct 2024 – Sep 2025
- Morehouse General HospitalBastrop, LAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendly51% would definitely recommend itOverall rating: 2 of 5 starsNo measure marked better or worse than the national rate
- Union General HospitalFarmerville, LACritical Access Hospital · Voluntary non-profit - Private · Has an emergency department86% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
See every measure and the patient survey for Fmol Health St Francis
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.498 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.423 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.25 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,295 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.68 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.53 (137.33 to 239.73) · 91 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.7 · 74 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 11 · 103 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 287 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.9 · 386 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.4 · 445 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.8 · 357 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 3,596 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.05 to 0.45) · 6,050 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.42) · 6,147 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.4 (2.4 to 6.41) · 1,640 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.39 (0 to 2.97) · 461 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.73 (1.3 to 4.17) · 1,544 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 14.39 (7.67 to 21.1) · 483 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.53 (0.82 to 8.25) · 451 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.35) · 378 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.76) · 5,530 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 30 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.594 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.544 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 484 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.2 · 680 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 9.2 · 292 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -5.7 · 422 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 19.9 · 448 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18 · 614 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.4 to 7) · 231 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.7 (8.9 to 15.1) · 231 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.9 · 99 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 204 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.6 to 17) · 184 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 551 cases | No different | Jan 2024 – Dec 2024 |
What patients said (598 patients answered, 23% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 63% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 52% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Franklin Medical Center
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Safety: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 1 better, 2 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.48 to 1.48) | No different | Jul 2022 – Jun 2024 |
| Death rate for pneumonia patientsComplications and deaths | 13.2 · 74 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.1 · 190 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 525 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.48) · 505 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.48 (0.85 to 6.12) · 33 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (0.94 to 4.41) · 32 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.82) · 393 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 1.186 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.4 · 32 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4 · 84 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.6 · 85 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (9.4 to 17.3) · 65 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.4) · 44 cases | No different | Jan 2024 – Dec 2024 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 90% |
| Doctors "always" communicated well | 92% |
| Staff "always" explained | 71% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 91% |
| Doctors "always" listened carefully | 91% |
| Doctors "always" treated them with courtesy and respect | 95% |
| Patients who gave a rating of "9" or "10" (high) | 80% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 85% |
| Nurses "always" listened carefully | 93% |
| Nurses "always" treated them with courtesy and respect | 93% |
| "Always" quiet at night | 81% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 64% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Glenwood Regional Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 3 the same, 2 worse of 6 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.062 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 707 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.67 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 168.52 (112.43 to 224.6) · 38 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 5.6 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 71 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.4 · 174 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.5 · 282 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 228 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.1 · 117 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.9 · 1,248 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 4,250 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.03 to 0.44) · 4,303 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.03 (1.78 to 6.28) · 913 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.55 (0 to 3.21) · 282 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.9 (1.36 to 4.44) · 927 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.04 (3.78 to 20.29) · 293 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.36 (1.33 to 9.39) · 251 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.15) · 177 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.43 (0 to 1.18) · 3,097 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.7 · 28 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.95 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.889 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.421 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 225 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 23.5 · 421 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 0.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 25.6 · 348 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -2.3 · 253 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.5 · 283 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 47 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 97 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (9.9 to 18.4) · 47 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 74 cases | No different | Jan 2024 – Dec 2024 |
What patients said (415 patients answered, 18% of those asked)
| Cleanliness | 3 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 5 |
| Recommend hospital | 4 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 87% |
| Doctors "always" communicated well | 87% |
| Staff "always" explained | 70% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 80% |
| Doctors "always" explained things so they could understand | 84% |
| Doctors "always" listened carefully | 85% |
| Doctors "always" treated them with courtesy and respect | 91% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 80% |
| Nurses "always" explained things so they could understand | 82% |
| Nurses "always" listened carefully | 87% |
| Nurses "always" treated them with courtesy and respect | 91% |
| "Always" quiet at night | 71% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 59% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Morehouse General Hospital
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 3 the same, 1 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for heart failure patientsComplications and deaths | 11.3 · 30 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.8 · 43 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.1 · 164 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 319 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.49) · 322 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.58 (0 to 1.88) · 245 cases | No different | Jul 2022 – Jun 2024 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 45 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 47.4 · 30 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 63.8 · 42 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 58 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 30 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (9.6 to 17) · 578 cases | No different | Jan 2022 – Dec 2024 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 69% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 60% |
| Staff "always" explained new medications | 88% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 73% |
| "YES", patients would definitely recommend the hospital | 51% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 82% |
See every measure and the patient survey for Union General Hospital
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 2 the same, 0 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for pneumonia patientsComplications and deaths | 17.2 · 50 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.3 · 64 cases | None | Jul 2024 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 11.9 · 64 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.6 to 18.3) · 33 cases | No different | Jan 2022 – Dec 2024 |
| Room was "always" clean | 97% |
| Nurses "always" communicated well | 97% |
| Doctors "always" communicated well | 98% |
| Staff "always" explained | 88% |
| Yes, staff "did" give patients this information | 89% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| "Always" quiet at night | 77% |
| "YES", patients would definitely recommend the hospital | 86% |
Original Medicare doctor bills
$225,623
Medicare paid this office $225,623 for 405 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 71 | $83,597 | $273 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 57 | $25,607 | $225 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 161 | $23,881 | $61 |
| Hemodialysis procedure with physician evaluation | 113 | $18,516 | $55 |
| Home dialysis services per month (20 years or older) | 37 | $18,377 | $227 |
See all 11 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 71 | $83,597 | $273 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 57 | $25,607 | $225 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 161 | $23,881 | $61 |
| Hemodialysis procedure with physician evaluation | 113 | $18,516 | $55 |
| Home dialysis services per month (20 years or older) | 37 | $18,377 | $227 |
| Return visit (30+ min) | 83 | $15,023 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 73 | $9,702 | $133 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $8,631 | $91 |
| Long return visit (40+ min) | 32 | $6,858 | $134 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 50 | $5,691 | $98 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 88 | $2,003 | $13 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 40 | 27 | 23 | 25 | – | – |
| Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | 31 | 24 | 34 | 21 | – | – |
| Removal of tunneled central venous tube | 14 | 23 | 20 | 12 | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
405 Original Medicare patients in 2024. Average age 70 · Under 65 26% · 85 and older 11% · Women 51% · Also on Medicaid 45% · Health risk score 5.72. Above the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 66% · Coronary heart disease 61% · Heart failure 60% · Atrial fibrillation 40% · COPD 30% · Depression 30% · Dementia 22% · Stroke 19% · Cancer 18%.
The office billed $579,800, Medicare allowed $283,540 and paid $225,623; for 2,001 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 405 | 2,001 | 70 | 5.72 | $579,800 | $225,623 |
| 2023 | 436 | 2,512 | 70 | 5.83 | $610,451 | $227,663 |
| 2022 | 503 | 5,443 | 69 | 5.57 | $736,159 | $267,093 |
| 2021 | 529 | 5,526 | 68 | 5.86 | $833,424 | $321,201 |
| 2020 | 739 | 6,745 | 67 | 6.26 | $1,081,059 | $391,277 |
| 2019 | 778 | 6,824 | 66 | 6.20 | $1,123,036 | $409,881 |
| 2018 | 830 | 9,040 | 67 | 5.87 | $1,221,274 | $425,811 |
| 2017 | 752 | 8,366 | 66 | 6.45 | $1,259,740 | $427,238 |
| 2016 | 766 | 8,813 | 66 | 6.09 | $1,349,531 | $431,166 |
| 2015 | 790 | 10,710 | 66 | 5.83 | $1,484,668 | $479,322 |
| 2014 | 787 | 14,161 | 66 | 5.33 | $1,683,108 | $516,235 |
| 2013 | 831 | 17,328 | 67 | 5.34 | $1,770,644 | $539,959 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 104 | $98,120 | $266 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 162 | $23,923 | $59 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 53 | $18,197 | $217 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 114 | $15,054 | $128 |
| Hemodialysis procedure with physician evaluation | 101 | $13,902 | $54 |
| Return visit (30+ min) | 82 | $12,132 | $86 |
| Home dialysis services per month (20 years or older) | 29 | $10,459 | $213 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 39 | $8,505 | $90 |
| Long return visit (40+ min) | 32 | $4,898 | $117 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 35 | $3,998 | $98 |
2022: 17 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 76 | $87,524 | $268 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 175 | $28,303 | $153 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 207 | $26,407 | $55 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 23 | $22,867 | $915 |
| Hemodialysis procedure with physician evaluation | 136 | $19,151 | $56 |
| Home dialysis services per month (20 years or older) | 34 | $17,973 | $219 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 37 | $12,005 | $222 |
| Return visit (30+ min) | 81 | $11,845 | $89 |
| Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | 21 | $10,593 | $504 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 51 | $6,725 | $78 |
| Long return visit (40+ min) | 27 | $3,903 | $126 |
| Dialysis services, per day, less than full month service (20 years or older) | 16 | $1,876 | $7 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,569 | $105 |
| Removal of tunneled central venous tube | 12 | $1,230 | $102 |
| Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 42 | $836 | $0 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 20 | $782 | $36 |
| Injection, midazolam hydrochloride, per 1 mg | 25 | $6 | None |
2021: 17 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 75 | $107,719 | $275 |
| Home dialysis services per month (20 years or older) | 31 | $26,678 | $224 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 201 | $26,674 | $56 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 154 | $25,678 | $152 |
| Hemodialysis procedure with physician evaluation | 160 | $23,701 | $56 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 21 | $22,499 | $978 |
| Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | 34 | $18,545 | $545 |
| Return visit (30+ min) | 97 | $14,540 | $90 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 35 | $12,096 | $224 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 61 | $8,322 | $79 |
| Dialysis services, per day, less than full month service (20 years or older) | 23 | $2,285 | $8 |
| Removal of tunneled central venous tube | 20 | $2,144 | $107 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,614 | $108 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 26 | $1,107 | $38 |
| Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 57 | $792 | $0 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 16 | $237 | $14 |
| Injection, midazolam hydrochloride, per 1 mg | 29 | $6 | None |
2020: 17 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 195 | $140,265 | $222 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 199 | $33,875 | $156 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 102 | $31,671 | $185 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 249 | $29,621 | $57 |
| Hemodialysis procedure with physician evaluation | 203 | $27,117 | $58 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 27 | $25,391 | $940 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 94 | $17,030 | $83 |
| Home dialysis services per month (20 years or older) | 31 | $13,993 | $187 |
| Return visit (30+ min) | 102 | $12,368 | $69 |
| Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | 23 | $11,985 | $499 |
| Dialysis services, per day, less than full month service (20 years or older) | 33 | $3,828 | $6 |
| Removal of tunneled central venous tube | 23 | $2,698 | $117 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,204 | $105 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 24 | $974 | $37 |
| Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 60 | $882 | $0 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $417 | $38 |
| Injection, midazolam hydrochloride, per 1 mg | 27 | $5 | None |
2019: 13 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 234 | $151,764 | $219 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 288 | $41,619 | $57 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 32 | $36,834 | $921 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 209 | $34,956 | $156 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 109 | $29,372 | $186 |
| Hemodialysis procedure with physician evaluation | 176 | $24,966 | $58 |
| Return visit (30+ min) | 123 | $22,204 | $73 |
| Home dialysis services per month (20 years or older) | 49 | $17,299 | $180 |
| Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | 30 | $14,275 | $460 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 80 | $12,132 | $82 |
| Removal of tunneled central venous tube | 13 | $1,620 | $116 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,298 | $108 |
| Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 65 | $961 | $0 |
2018: 16 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 191 | $122,456 | $215 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 57 | $55,878 | $901 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 348 | $50,832 | $56 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 244 | $40,360 | $155 |
| Hemodialysis procedure with physician evaluation | 186 | $27,874 | $56 |
| Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | 46 | $20,628 | $430 |
| Return visit (30+ min) | 129 | $20,627 | $73 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 77 | $19,785 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 100 | $15,906 | $80 |
| Home dialysis services per month (20 years or older) | 46 | $14,194 | $173 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 41 | $4,410 | $105 |
| Hemodialysis procedure requiring repeated evaluation | 25 | $2,930 | $79 |
| Dialysis services, 1 physician visit per month (20 years or older) | 15 | $2,275 | $134 |
| Long return visit (40+ min) | 15 | $1,551 | $103 |
| Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 102 | $1,504 | $0 |
| Short return visit (20+ min) | 14 | $719 | $51 |
2017: 19 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 250 | $143,563 | $209 |
| Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist | 51 | $48,013 | $873 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 261 | $42,813 | $56 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 121 | $31,407 | $182 |
| Hemodialysis procedure with physician evaluation | 170 | $27,376 | $56 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 137 | $23,332 | $157 |
| Return visit (30+ min) | 124 | $20,583 | $74 |
| Home dialysis services per month (20 years or older) | 35 | $14,631 | $183 |
| Insertion of needle and/or tube into hemodialysis circuit with review by radiologist | 32 | $13,616 | $413 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 83 | $11,257 | $79 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 58 | $6,618 | $107 |
| Hemodialysis procedure requiring repeated evaluation | 32 | $3,651 | $81 |
| Removal of tunneled central venous tube | 20 | $2,479 | $124 |
| Dialysis services, 1 physician visit per month (20 years or older) | 17 | $2,395 | $141 |
| Long return visit (40+ min) | 16 | $1,434 | $84 |
| Short return visit (20+ min) | 29 | $1,418 | $43 |
| Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 87 | $983 | $0 |
| Short return visit | 18 | $521 | $27 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 22 | $409 | $15 |
2016: 35 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 225 | $110,061 | $207 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 310 | $49,539 | $54 |
| Balloon dilation of narrowed or blocked vein, accessed through the skin | 42 | $41,144 | $875 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 117 | $31,519 | $174 |
| Hemodialysis procedure with physician evaluation | 186 | $26,256 | $55 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 154 | $25,278 | $151 |
| Insertion of needle and/or catheter for dialysis | 56 | $24,148 | $377 |
| Return visit (30+ min) | 126 | $18,985 | $73 |
| Home dialysis services per month (20 years or older) | 42 | $17,511 | $173 |
| Catheter removal of blood clot from dialysis graft, accessed through the skin | 11 | $16,886 | $1,299 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 105 | $11,266 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 83 | $11,131 | $77 |
| Long return visit (40+ min) | 50 | $6,425 | $99 |
| Hemodialysis procedure requiring repeated evaluation | 35 | $5,236 | $79 |
| Radiological supervision and interpretation of balloon dilation of narrowed vein | 41 | $4,509 | $98 |
| Insertion of needle and/or catheter into an artery-vein dialysis shunt or graft | 13 | $2,798 | $187 |
| Dialysis services, 1 physician visit per month (20 years or older) | 19 | $2,627 | $138 |
| Insertion of tube into vena cava | 12 | $2,160 | $180 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 106 | $1,798 | $10 |
| Removal of tunneled central venous tube | 13 | $1,505 | $116 |
| Short return visit (20+ min) | 25 | $1,076 | $41 |
| Blood test, comprehensive group of blood chemicals | 105 | $724 | $4 |
| Lactate dehydrogenase (enzyme) level | 106 | $581 | $3 |
| Phosphate level | 106 | $579 | $3 |
| Uric acid level, blood | 106 | $578 | $3 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 11 | $547 | $50 |
| Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 64 | $531 | $0 |
| Automated urinalysis test | 102 | $481 | $3 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 17 | $387 | $14 |
| Short return visit | 11 | $348 | $32 |
| Administration of influenza virus vaccine | 12 | $275 | $23 |
| Creatinine level to test for kidney function or muscle injury | 21 | $180 | $7 |
| Total protein level, urine | 19 | $118 | $5 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) | 12 | $101 | $8 |
| Insertion of needle into vein for collection of blood sample | 21 | $74 | $3 |
2015: 32 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 252 | $121,284 | $219 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 332 | $56,404 | $56 |
| Balloon dilation of narrowed or blocked vein, accessed through the skin | 47 | $55,882 | $963 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 153 | $51,123 | $181 |
| Hemodialysis procedure with physician evaluation | 196 | $34,930 | $57 |
| Insertion of needle and/or catheter for dialysis | 63 | $28,698 | $373 |
| Return visit (30+ min) | 135 | $22,770 | $73 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 146 | $17,385 | $107 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 84 | $13,616 | $157 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 69 | $9,619 | $81 |
| Home dialysis services per month (20 years or older) | 27 | $9,147 | $183 |
| Radiological supervision and interpretation of balloon dilation of narrowed vein | 46 | $5,494 | $98 |
| Hemodialysis procedure requiring repeated evaluation | 35 | $4,130 | $81 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 140 | $3,817 | $10 |
| Insertion of needle and/or catheter into an artery-vein dialysis shunt or graft | 17 | $3,307 | $184 |
| Dialysis services, 1 physician visit per month (20 years or older) | 19 | $2,815 | $141 |
| Short return visit (20+ min) | 44 | $2,687 | $49 |
| New patient visit (45+ min) | 21 | $2,516 | $120 |
| Blood test, comprehensive group of blood chemicals | 139 | $1,549 | $4 |
| Removal of tunneled central venous tube | 12 | $1,298 | $108 |
| Lactate dehydrogenase (enzyme) level | 140 | $1,232 | $3 |
| Uric acid level, blood | 140 | $1,230 | $3 |
| Phosphate level | 140 | $1,225 | $3 |
| Automated urinalysis test | 133 | $972 | $3 |
| Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 64 | $626 | $0 |
| Injection of drug or substance under skin or into muscle | 11 | $477 | $18 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $307 | $14 |
| Creatinine level to test for kidney function or muscle injury | 33 | $287 | $6 |
| Administration of influenza virus vaccine | 12 | $276 | $23 |
| Total protein level, urine | 32 | $203 | $4 |
| Insertion of needle into vein for collection of blood sample | 40 | $194 | $3 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) | 12 | $101 | $8 |
2014: 35 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 182 | $93,417 | $215 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 360 | $74,365 | $54 |
| Balloon dilation of narrowed or blocked vein, accessed through the skin | 66 | $73,445 | $954 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 152 | $47,629 | $181 |
| Hemodialysis procedure with physician evaluation | 189 | $39,013 | $55 |
| Insertion of needle and/or catheter for dialysis | 83 | $32,654 | $340 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 196 | $23,376 | $103 |
| Return visit (30+ min) | 125 | $20,565 | $71 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 69 | $10,840 | $151 |
| Radiological supervision and interpretation of balloon dilation of narrowed vein | 65 | $7,685 | $102 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 52 | $7,584 | $79 |
| Dialysis services, 1 physician visit per month (20 years or older) | 49 | $7,201 | $133 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 12 | $6,825 | $569 |
| Hemodialysis procedure requiring repeated evaluation | 60 | $6,569 | $80 |
| Injection, epoetin alfa, (for non-esrd use), 1000 units | 14 | $5,414 | None |
| Insertion of needle and/or catheter into an artery-vein dialysis shunt or graft | 26 | $5,240 | $187 |
| Short return visit (20+ min) | 69 | $4,502 | $48 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 148 | $3,969 | $10 |
| Insertion of tube into vena cava | 15 | $2,716 | $181 |
| Hospital discharge day management, 30 minutes or less | 31 | $2,188 | $55 |
| Blood test, comprehensive group of blood chemicals | 147 | $1,617 | $4 |
| Uric acid level, blood | 147 | $1,278 | $3 |
| Phosphate level | 147 | $1,268 | $3 |
| Lactate dehydrogenase (enzyme) level | 147 | $1,266 | $3 |
| Removal of tunneled central venous tube | 12 | $1,214 | $101 |
| Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 95 | $979 | $0 |
| Automated urinalysis test | 132 | $946 | $3 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 15 | $849 | $57 |
| Injection of drug or substance under skin or into muscle | 20 | $807 | $18 |
| Administration of influenza virus vaccine | 12 | $269 | $22 |
| Insertion of needle into vein for collection of blood sample | 47 | $183 | $3 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 12 | $181 | $15 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $151 | $8 |
| Creatinine level to test for kidney function or muscle injury | 18 | $118 | $7 |
| Total protein level, urine | 18 | $84 | $5 |
2013: 37 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 273 | $111,529 | $210 |
| Balloon dilation of narrowed or blocked vein, accessed through the skin | 65 | $76,689 | $935 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 343 | $76,109 | $53 |
| Hemodialysis procedure with physician evaluation | 186 | $37,593 | $54 |
| Insertion of needle and/or catheter for dialysis | 81 | $36,372 | $367 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 148 | $31,742 | $176 |
| Catheter removal of blood clot from dialysis graft, accessed through the skin | 16 | $23,214 | $1,366 |
| Return visit (30+ min) | 126 | $21,839 | $72 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 125 | $18,929 | $148 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 109 | $12,087 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 75 | $11,709 | $75 |
| Hemodialysis procedure requiring repeated evaluation | 69 | $10,237 | $77 |
| Radiological supervision and interpretation of balloon dilation of narrowed vein | 64 | $8,529 | $107 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 12 | $6,955 | $580 |
| Insertion of needle and/or catheter into an artery-vein dialysis shunt or graft | 24 | $5,220 | $193 |
| Short return visit (20+ min) | 65 | $4,107 | $46 |
| Hospital discharge day management, 30 minutes or less | 64 | $3,909 | $53 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 141 | $3,850 | $10 |
| Insertion of tube into vena cava | 18 | $3,501 | $184 |
| Dialysis services, 1 physician visit per month (20 years or older) | 17 | $2,321 | $137 |
| Removal of tunneled central venous tube | 20 | $2,231 | $112 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 28 | $2,098 | $75 |
| Creatinine level to test for kidney function or muscle injury | 111 | $1,695 | $7 |
| Blood test, comprehensive group of blood chemicals | 138 | $1,536 | $4 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 18 | $1,527 | $85 |
| Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 93 | $1,334 | $0 |
| Lactate dehydrogenase (enzyme) level | 139 | $1,232 | $3 |
| Phosphate level | 140 | $1,227 | $3 |
| Uric acid level, blood | 140 | $1,226 | $3 |
| Total protein level, urine | 111 | $1,171 | $5 |
| Automated urinalysis test | 123 | $926 | $3 |
| Injection of drug or substance under skin or into muscle | 23 | $698 | $18 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $460 | $29 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 17 | $355 | $13 |
| Administration of influenza virus vaccine | 15 | $343 | $23 |
| Insertion of needle into vein for collection of blood sample | 63 | $288 | $3 |
| Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) | 15 | $126 | $8 |
Medicaid work
$30,419 in 2024
Medicaid paid $30,419 for 1,066 billed services this clinician did in 2024, up to 31 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 195 | $13,162 |
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 459 | $11,569 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 182 | $3,760 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 93 | $913 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 19 | $626 |
| Return visit (30+ min) | 13 | $376 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 39 | $13 |
| Syringe, with or without needle, each | 66 | $0 |
| 2024 | 1,066 | 8 | 31 | $30,419 |
| 2023 | 3,105 | 22 | 53 | $45,371 |
| 2022 | 4,456 | 16 | 40 | $33,554 |
| 2021 | 4,782 | 16 | 38 | $57,481 |
| 2020 | 6,228 | 27 | 70 | $86,517 |
| 2019 | 2,749 | 14 | 88 | $27,679 |
| 2018 | 1,825 | 8 | 56 | $33,699 |
See the largest Medicaid services in earlier years
2023
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 299 | $24,409 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 374 | $15,047 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 251 | $3,667 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 84 | $1,370 |
| Return visit (30+ min) | 15 | $501 |
| 1ST HOSP IP/OBS HIGH 75 | 19 | $377 |
| ELECTROLYTE PANEL | 25 | $0 |
| Measurement of albumin in serum | 25 | $0 |
| Measurement of aluminum | 28 | $0 |
| CALCIUM TOTAL | 16 | $0 |
| Creatinine; blood | 17 | $0 |
| Measurement of ferritin | 42 | $0 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 343 | $16,591 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 371 | $7,613 |
| 1ST HOSP IP/OBS HIGH 75 | 148 | $6,088 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 241 | $3,105 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 13 | $157 |
| Measurement of aluminum | 31 | $0 |
| Measurement of ferritin | 49 | $0 |
| Measurement of iron | 108 | $0 |
| IRON BINDING CAPACITY | 78 | $0 |
| Measurement of magnesium | 15 | $0 |
| Parathormone (parathyroid hormone) | 41 | $0 |
| Urea nitrogen; quantitative | 93 | $0 |
2021
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 521 | $28,855 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 334 | $11,742 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 445 | $6,842 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 369 | $5,056 |
| 1ST HOSP IP/OBS HIGH 75 | 114 | $4,985 |
| Measurement of aluminum | 45 | $0 |
| Measurement of ferritin | 80 | $0 |
| Measurement of iron | 218 | $0 |
| IRON BINDING CAPACITY | 214 | $0 |
| Measurement of magnesium | 73 | $0 |
| Parathormone (parathyroid hormone) | 69 | $0 |
| Urea nitrogen; quantitative | 45 | $0 |
2020
| UNLISTED DIALYSIS PROCEDURE INPATIENT/OUTPATIENT | 868 | $58,167 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 480 | $11,679 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 363 | $5,385 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 367 | $4,475 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 115 | $4,319 |
| 1ST HOSP IP/OBS HIGH 75 | 91 | $1,230 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 27 | $676 |
| Return visit (30+ min) | 13 | $432 |
| End-stage renal disease (ESRD) related services for home dialysis per full month, for patients 20 years of age and older | 13 | $155 |
| ELECTROLYTE PANEL | 83 | $0 |
| Renal function panel This panel must include the following: Albumin (82040) Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Phosphorus inorganic (phosphate) (84100) Potassium (84132) Sodium (84295) Urea nitrogen (BUN) (84520) | 31 | $0 |
| Measurement of albumin in serum | 95 | $0 |
2019
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 521 | $12,075 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 524 | $7,387 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 316 | $2,968 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 61 | $2,262 |
| Return visit (30+ min) | 55 | $1,637 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 67 | $1,096 |
| 1ST HOSP IP/OBS HIGH 75 | 26 | $254 |
| Measurement of aluminum | 27 | $0 |
| Measurement of ferritin | 39 | $0 |
| Measurement of iron | 104 | $0 |
| IRON BINDING CAPACITY | 79 | $0 |
| Measurement of magnesium | 13 | $0 |
2018
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 463 | $14,131 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 666 | $8,588 |
| Hemodialysis procedure with single evaluation by a physician or other qualified health care professional | 410 | $4,833 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 140 | $4,770 |
| 1ST HOSP IP/OBS HIGH 75 | 90 | $656 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 29 | $470 |
| Return visit (30+ min) | 13 | $251 |
| Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 14 | $0 |
Drugs they prescribed that Part D paid
$638,779
Pharmacies billed $638,779 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (64 of 1,619) in 2024. A higher opioid share than 9 in 10 peers; the typical nephrology clinician is at 0%.
1,201 generic and fewer than 11 brand-name prescriptions · $638,779 in drug cost · 14 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Velphoro | 121 | $357,741 | $2,957 |
| Auryxia | 98 | $135,637 | $1,384 |
| Farxiga | 53 | $37,100 | $700 |
| Kerendia | 45 | $34,994 | $778 |
| Procrit | 20 | $23,409 | $1,170 |
See all 33 drugs
| Velphoro | 121 | $357,741 | $2,957 |
| Auryxia | 98 | $135,637 | $1,384 |
| Farxiga | 53 | $37,100 | $700 |
| Kerendia | 45 | $34,994 | $778 |
| Procrit | 20 | $23,409 | $1,170 |
| Eliquis | 13 | $7,579 | $583 |
| Sevelamer Carbonate | 65 | $5,862 | $90 |
| Cholestyramine | 12 | $1,465 | $122 |
| Bumetanide | 39 | $1,451 | $37 |
| Nifedipine Er | 57 | $1,355 | $24 |
| Telmisartan | 51 | $1,353 | $27 |
| Hydralazine | 61 | $849 | $14 |
| Metoprolol | 46 | $743 | $16 |
| Midodrine | 20 | $582 | $29 |
| Metoprolol | 87 | $474 | $5 |
| Amlodipine Besylate | 67 | $433 | $6 |
| Furosemide | 68 | $397 | $6 |
| Atorvastatin | 26 | $357 | $14 |
| Allopurinol | 36 | $343 | $10 |
| Hydrocodone-Acetaminophen | 27 | $317 | $12 |
| Metoclopramide | 42 | $230 | $5 |
| Levothyroxine | 34 | $226 | $7 |
| Clonidine | 29 | $204 | $7 |
| Losartan | 20 | $199 | $10 |
| Carvedilol | 50 | $190 | $4 |
| Lisinopril | 15 | $155 | $10 |
| Calcitriol | 16 | $127 | $8 |
| Tramadol | 37 | $113 | $3 |
| Doxazosin Mesylate | 13 | $91 | $7 |
| Pantoprazole | 19 | $73 | $4 |
| Gabapentin | 20 | $59 | $3 |
| Hydrochlorothiazide | 11 | $38 | $3 |
| Escitalopram | 22 | $20 | $1 |
Year by year
| 2024 | 1,619 | 244 | 4% (64) | None | $638,779 |
| 2023 | 1,421 | 214 | 2% (29) | None | $559,619 |
| 2022 | 1,279 | 198 | 2% (23) | None | $388,433 |
| 2021 | 1,497 | 199 | 3% (51) | 24% | $616,434 |
| 2020 | 1,677 | 247 | 3% (54) | 22% | $537,656 |
| 2019 | 1,716 | 243 | 4% (71) | 21% | $475,159 |
| 2018 | 2,124 | 235 | 4% (78) | None | $566,885 |
| 2017 | 2,650 | 262 | 3% (86) | None | $951,320 |
| 2016 | 2,954 | 268 | 3% (95) | 35% | $842,254 |
| 2015 | 3,284 | 287 | 4% (127) | 31% | $645,871 |
| 2014 | 3,622 | 315 | 5% (172) | 34% | $784,875 |
| 2013 | 3,742 | 330 | 6% (217) | 35% | $646,496 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 33 drugs
| Velphoro | 117 | $323,297 | $2,763 |
| Auryxia | 70 | $125,410 | $1,792 |
| Kerendia | 24 | $21,669 | $903 |
| Procrit | 15 | $18,029 | $1,202 |
| Sevelamer Carbonate | 75 | $11,066 | $148 |
| Eliquis | 12 | $7,325 | $610 |
| Nifedipine Er | 54 | $1,912 | $35 |
| Midodrine | 29 | $1,171 | $40 |
| Furosemide | 71 | $947 | $13 |
| Hydralazine | 48 | $846 | $18 |
| Potassium Chloride | 41 | $796 | $19 |
| Telmisartan | 25 | $748 | $30 |
| Levothyroxine | 54 | $669 | $12 |
| Allopurinol | 45 | $640 | $14 |
| Metoprolol | 32 | $585 | $18 |
| Colchicine | 11 | $521 | $47 |
| Amlodipine Besylate | 82 | $495 | $6 |
| Bumetanide | 14 | $475 | $34 |
| Hydrocodone-Acetaminophen | 12 | $432 | $36 |
| Losartan | 30 | $413 | $14 |
| Metoprolol | 61 | $403 | $7 |
| Atorvastatin | 19 | $403 | $21 |
| Lisinopril | 34 | $400 | $12 |
| Carvedilol | 42 | $368 | $9 |
| Doxazosin Mesylate | 13 | $317 | $24 |
| Gabapentin | 37 | $282 | $8 |
| Calcitriol | 13 | $221 | $17 |
| Tramadol | 17 | $192 | $11 |
| Lidocaine-Prilocaine | 13 | $180 | $14 |
| Escitalopram | 19 | $88 | $5 |
| Spironolactone | 16 | $78 | $5 |
| Lactulose | 11 | $70 | $6 |
| Clonidine | 11 | $42 | $4 |
2022: 34 drugs
| Velphoro | 65 | $174,346 | $2,682 |
| Auryxia | 65 | $125,059 | $1,924 |
| Renvela | 17 | $15,467 | $910 |
| Procrit | 12 | $13,154 | $1,096 |
| Eliquis | 22 | $12,342 | $561 |
| Sevelamer Carbonate | 49 | $9,242 | $189 |
| Retacrit | 13 | $5,796 | $446 |
| Nifedipine Er | 60 | $3,299 | $55 |
| Midodrine | 18 | $1,817 | $101 |
| Bumetanide | 17 | $1,134 | $67 |
| Telmisartan | 16 | $1,001 | $63 |
| Levothyroxine | 47 | $901 | $19 |
| Metoprolol | 40 | $699 | $17 |
| Allopurinol | 33 | $626 | $19 |
| Potassium Chloride | 34 | $614 | $18 |
| Atorvastatin | 21 | $468 | $22 |
| Furosemide | 67 | $418 | $6 |
| Clopidogrel | 12 | $392 | $33 |
| Losartan | 31 | $385 | $12 |
| Hydrocodone-Acetaminophen | 12 | $383 | $32 |
| Amlodipine Besylate | 80 | $382 | $5 |
| Hydralazine | 41 | $342 | $8 |
| Carvedilol | 40 | $324 | $8 |
| Metoprolol | 57 | $322 | $6 |
| Lisinopril | 27 | $312 | $12 |
| Metolazone | 14 | $281 | $20 |
| Gabapentin | 25 | $280 | $11 |
| Escitalopram | 16 | $210 | $13 |
| Clonidine | 25 | $193 | $8 |
| Doxazosin Mesylate | 11 | $130 | $12 |
| Tramadol | 11 | $126 | $11 |
| Doxycycline Hyclate | 18 | $103 | $6 |
| Simvastatin | 12 | $92 | $8 |
| Ramipril | 11 | $7 | $1 |
2021: 35 drugs
| Velphoro | 92 | $338,624 | $3,681 |
| Auryxia | 76 | $146,745 | $1,931 |
| Renvela | 22 | $45,721 | $2,078 |
| Procrit | 18 | $20,614 | $1,145 |
| Sevelamer Carbonate | 76 | $10,612 | $140 |
| Nifedipine Er | 60 | $3,876 | $65 |
| Ezetimibe | 11 | $2,201 | $200 |
| Bumetanide | 27 | $1,538 | $57 |
| Metoprolol | 38 | $958 | $25 |
| Levothyroxine | 60 | $928 | $15 |
| Telmisartan | 17 | $828 | $49 |
| Potassium Chloride | 41 | $778 | $19 |
| Midodrine | 27 | $712 | $26 |
| Losartan | 44 | $701 | $16 |
| Allopurinol | 34 | $589 | $17 |
| Gabapentin | 55 | $499 | $9 |
| Hydrocodone-Acetaminophen | 17 | $494 | $29 |
| Amlodipine Besylate | 85 | $482 | $6 |
| Pregabalin | 12 | $418 | $35 |
| Furosemide | 51 | $307 | $6 |
| Lisinopril | 29 | $292 | $10 |
| Atorvastatin | 15 | $289 | $19 |
| Finasteride | 11 | $261 | $24 |
| Doxazosin Mesylate | 13 | $222 | $17 |
| Simvastatin | 14 | $215 | $15 |
| Tramadol | 34 | $199 | $6 |
| Lactulose | 12 | $189 | $16 |
| Carvedilol | 32 | $184 | $6 |
| Hydralazine | 22 | $182 | $8 |
| Escitalopram | 19 | $158 | $8 |
| Spironolactone | 16 | $132 | $8 |
| Clopidogrel | 17 | $100 | $6 |
| Metformin | 17 | $100 | $6 |
| Metoprolol | 30 | $84 | $3 |
| Meloxicam | 13 | $55 | $4 |
2020: 41 drugs
| Velphoro | 69 | $262,331 | $3,802 |
| Auryxia | 86 | $125,130 | $1,455 |
| Renvela | 51 | $60,619 | $1,189 |
| Sevelamer Carbonate | 118 | $21,031 | $178 |
| Cinacalcet | 13 | $7,150 | $550 |
| Colcrys | 14 | $5,669 | $405 |
| Bystolic | 13 | $3,544 | $273 |
| Nifedipine Er | 42 | $2,212 | $53 |
| Telmisartan | 34 | $1,804 | $53 |
| Pregabalin | 16 | $1,229 | $77 |
| Levothyroxine | 73 | $1,041 | $14 |
| Bumetanide | 18 | $1,002 | $56 |
| Eplerenone | 11 | $884 | $80 |
| Midodrine | 30 | $802 | $27 |
| Metoprolol | 20 | $504 | $25 |
| Clonidine | 24 | $495 | $21 |
| Amlodipine Besylate | 83 | $494 | $6 |
| Simvastatin | 19 | $484 | $25 |
| Losartan | 37 | $426 | $12 |
| Carvedilol | 40 | $409 | $10 |
| Potassium Chloride | 24 | $376 | $16 |
| Doxycycline Hyclate | 14 | $351 | $25 |
| Hydralazine | 22 | $350 | $16 |
| Furosemide | 83 | $345 | $4 |
| Hydrocodone-Acetaminophen | 23 | $282 | $12 |
| Lisinopril | 46 | $272 | $6 |
| Allopurinol | 20 | $270 | $14 |
| Gabapentin | 46 | $243 | $5 |
| Atorvastatin | 18 | $223 | $12 |
| Pantoprazole | 16 | $215 | $13 |
| Escitalopram | 25 | $184 | $7 |
| Metoprolol | 51 | $162 | $3 |
| Doxazosin Mesylate | 13 | $147 | $11 |
| Finasteride | 11 | $146 | $13 |
| Clopidogrel | 17 | $142 | $8 |
| Lactulose | 13 | $136 | $10 |
| Tramadol | 31 | $125 | $4 |
| Isosorbide Mononitrate Er | 15 | $84 | $6 |
| Glipizide | 16 | $54 | $3 |
| Meloxicam | 13 | $54 | $4 |
| Metformin | 15 | $45 | $3 |
2019: 48 drugs
| Velphoro | 82 | $218,291 | $2,662 |
| Auryxia | 44 | $53,307 | $1,212 |
| Sevelamer Carbonate | 80 | $45,383 | $567 |
| Renvela | 21 | $17,794 | $847 |
| Bystolic | 20 | $3,824 | $191 |
| Paricalcitol | 13 | $2,055 | $158 |
| Ezetimibe | 13 | $1,318 | $101 |
| Eplerenone | 12 | $1,096 | $91 |
| Nifedipine Er | 25 | $926 | $37 |
| Bumetanide | 15 | $902 | $60 |
| Levothyroxine | 61 | $882 | $14 |
| Metoprolol | 35 | $636 | $18 |
| Labetalol | 11 | $570 | $52 |
| Simvastatin | 19 | $547 | $29 |
| Telmisartan | 18 | $517 | $29 |
| Allopurinol | 31 | $488 | $16 |
| Potassium Chloride | 25 | $461 | $18 |
| Pravastatin | 14 | $450 | $32 |
| Amlodipine Besylate | 80 | $425 | $5 |
| Midodrine | 19 | $393 | $21 |
| Hydrocodone-Acetaminophen | 30 | $389 | $13 |
| Gabapentin | 40 | $381 | $10 |
| Furosemide | 71 | $334 | $5 |
| Losartan | 56 | $320 | $6 |
| Hydralazine | 28 | $279 | $10 |
| Atorvastatin | 41 | $273 | $7 |
| Doxazosin Mesylate | 16 | $265 | $17 |
| Carvedilol | 25 | $251 | $10 |
| Tamsulosin | 31 | $245 | $8 |
| Clonidine | 17 | $229 | $13 |
| Lisinopril | 43 | $206 | $5 |
| Escitalopram | 20 | $204 | $10 |
| Amlodipine Besylate-Benazepril | 17 | $193 | $11 |
| Tramadol | 39 | $177 | $5 |
| Irbesartan | 11 | $150 | $14 |
| Metoprolol | 39 | $146 | $4 |
| Spironolactone | 19 | $124 | $7 |
| Isosorbide Mononitrate Er | 18 | $121 | $7 |
| Clopidogrel | 15 | $120 | $8 |
| Torsemide | 12 | $114 | $10 |
| Metformin | 12 | $103 | $9 |
| Prednisone | 14 | $101 | $7 |
| Clonazepam | 16 | $73 | $5 |
| Ramipril | 11 | $62 | $6 |
| Alendronate | 12 | $40 | $3 |
| Glipizide | 13 | $40 | $3 |
| Warfarin | 20 | $38 | $2 |
| Hydrochlorothiazide | 11 | $23 | $2 |
2018: 61 drugs
| Renvela | 66 | $125,657 | $1,904 |
| Sevelamer Carbonate | 72 | $97,892 | $1,360 |
| Velphoro | 21 | $88,315 | $4,205 |
| Renagel | 14 | $68,529 | $4,895 |
| Auryxia | 47 | $43,388 | $923 |
| Procrit | 13 | $13,394 | $1,030 |
| Sensipar | 13 | $10,519 | $809 |
| Lyrica | 12 | $9,545 | $795 |
| Januvia | 14 | $9,282 | $663 |
| Colcrys | 17 | $4,334 | $255 |
| Ranexa | 11 | $4,206 | $382 |
| Bystolic | 25 | $4,181 | $167 |
| Chlorpromazine | 11 | $3,996 | $363 |
| Paricalcitol | 27 | $3,539 | $131 |
| Ezetimibe | 34 | $3,323 | $98 |
| Telmisartan | 59 | $2,703 | $46 |
| Potassium Chloride | 30 | $2,645 | $88 |
| Tacrolimus | 12 | $1,925 | $160 |
| Esomeprazole Magnesium | 13 | $1,468 | $113 |
| Levothyroxine | 81 | $1,198 | $15 |
| Calcium Acetate | 11 | $1,149 | $104 |
| Nifedipine Er | 19 | $1,048 | $55 |
| Labetalol | 14 | $859 | $61 |
| Allopurinol | 53 | $723 | $14 |
| Escitalopram | 24 | $655 | $27 |
| Tamsulosin | 51 | $636 | $12 |
| Megestrol Acetate | 14 | $606 | $43 |
| Rosuvastatin | 14 | $592 | $42 |
| Hydrocodone-Acetaminophen | 32 | $513 | $16 |
| Gabapentin | 56 | $499 | $9 |
| Amlodipine Besylate | 108 | $476 | $4 |
| Bumetanide | 14 | $469 | $34 |
| Furosemide | 127 | $453 | $4 |
| Calcitriol | 17 | $445 | $26 |
| Simvastatin | 41 | $414 | $10 |
| Pravastatin | 15 | $410 | $27 |
| Doxazosin Mesylate | 15 | $405 | $27 |
| Losartan | 56 | $398 | $7 |
| Atorvastatin | 44 | $396 | $9 |
| Metoprolol | 28 | $385 | $14 |
| Hydralazine | 21 | $362 | $17 |
| Clonidine | 30 | $308 | $10 |
| Carvedilol | 53 | $251 | $5 |
| Montelukast | 11 | $242 | $22 |
| Torsemide | 14 | $234 | $17 |
| Spironolactone | 29 | $227 | $8 |
| Tramadol | 46 | $227 | $5 |
| Metoprolol | 45 | $223 | $5 |
| Isosorbide Mononitrate Er | 21 | $205 | $10 |
| Clopidogrel | 19 | $188 | $10 |
| Irbesartan | 13 | $181 | $14 |
| Lisinopril | 35 | $169 | $5 |
| Chlorthalidone | 11 | $160 | $15 |
| Warfarin | 20 | $137 | $7 |
| Fluoxetine | 11 | $119 | $11 |
| Tizanidine | 11 | $111 | $10 |
| Prednisone | 21 | $111 | $5 |
| Meloxicam | 11 | $99 | $9 |
| Benazepril | 12 | $64 | $5 |
| Alendronate | 11 | $57 | $5 |
| Metformin | 12 | $27 | $2 |
2017: 55 drugs
| Renvela | 214 | $388,936 | $1,817 |
| Sensipar | 188 | $341,530 | $1,817 |
| Procrit | 23 | $22,678 | $986 |
| Sevelamer Carbonate | 15 | $18,003 | $1,200 |
| Zetia | 32 | $13,913 | $435 |
| Paricalcitol | 43 | $8,394 | $195 |
| Bystolic | 41 | $7,109 | $173 |
| Nexium | 14 | $3,586 | $256 |
| Colcrys | 12 | $3,279 | $273 |
| Telmisartan | 64 | $2,662 | $42 |
| Calcium Acetate | 19 | $1,792 | $94 |
| Levothyroxine | 128 | $1,581 | $12 |
| Fenofibrate | 22 | $1,410 | $64 |
| Metoprolol | 42 | $1,116 | $27 |
| Nifedipine Er | 39 | $839 | $22 |
| Megestrol Acetate | 21 | $797 | $38 |
| Hydralazine | 37 | $796 | $22 |
| Labetalol | 14 | $769 | $55 |
| Ventolin Hfa | 13 | $698 | $54 |
| Doxazosin Mesylate | 31 | $607 | $20 |
| Gabapentin | 88 | $552 | $6 |
| Hydrocodone-Acetaminophen | 45 | $532 | $12 |
| Calcitriol | 16 | $505 | $32 |
| Allopurinol | 40 | $504 | $13 |
| Duloxetine | 18 | $490 | $27 |
| Tamsulosin | 36 | $476 | $13 |
| Atorvastatin | 55 | $475 | $9 |
| Amlodipine Besylate | 132 | $473 | $4 |
| Potassium Chloride | 19 | $394 | $21 |
| Losartan | 55 | $358 | $7 |
| Isosorbide Mononitrate Er | 33 | $318 | $10 |
| Montelukast | 28 | $312 | $11 |
| Furosemide | 100 | $296 | $3 |
| Simvastatin | 50 | $267 | $5 |
| Tramadol | 41 | $267 | $7 |
| Metoprolol | 54 | $247 | $5 |
| Clonidine | 33 | $245 | $7 |
| Minoxidil | 23 | $239 | $10 |
| Escitalopram | 33 | $236 | $7 |
| Klor-Con M20 | 19 | $233 | $12 |
| Lisinopril | 56 | $188 | $3 |
| Pravastatin | 14 | $180 | $13 |
| Pantoprazole | 15 | $176 | $12 |
| Meloxicam | 27 | $154 | $6 |
| Spironolactone | 27 | $134 | $5 |
| Carvedilol | 26 | $129 | $5 |
| Alendronate | 22 | $128 | $6 |
| Prednisone | 27 | $117 | $4 |
| Warfarin | 15 | $105 | $7 |
| Tizanidine | 12 | $101 | $8 |
| Pioglitazone | 14 | $93 | $7 |
| Levofloxacin | 12 | $86 | $7 |
| Benazepril | 12 | $84 | $7 |
| Metoclopramide | 14 | $81 | $6 |
| Metformin | 13 | $42 | $3 |
2016: 66 drugs
| Renvela | 263 | $420,527 | $1,599 |
| Sensipar | 180 | $274,441 | $1,525 |
| Procrit | 20 | $18,674 | $934 |
| Zetia | 35 | $15,236 | $435 |
| Januvia | 15 | $9,067 | $604 |
| Paricalcitol | 26 | $6,504 | $250 |
| Bystolic | 48 | $5,649 | $118 |
| Nexium | 14 | $3,587 | $256 |
| Uloric | 12 | $3,390 | $283 |
| Clonidine | 24 | $3,313 | $138 |
| Calcium Acetate | 34 | $2,980 | $88 |
| Telmisartan | 58 | $2,603 | $45 |
| Colcrys | 11 | $2,218 | $202 |
| Colchicine | 11 | $2,089 | $190 |
| Doxazosin Mesylate | 62 | $1,816 | $29 |
| Levothyroxine | 156 | $1,756 | $11 |
| Metoprolol | 52 | $1,258 | $24 |
| Nifedipine Er | 51 | $1,172 | $23 |
| Fenofibrate | 34 | $1,111 | $33 |
| Megestrol Acetate | 31 | $882 | $28 |
| Hydrocodone-Acetaminophen | 58 | $836 | $14 |
| Labetalol | 12 | $832 | $69 |
| Atorvastatin | 57 | $753 | $13 |
| Duloxetine | 26 | $748 | $29 |
| Allopurinol | 41 | $574 | $14 |
| Losartan | 96 | $535 | $6 |
| Valsartan | 18 | $480 | $27 |
| Potassium Chloride | 33 | $454 | $14 |
| Calcitriol | 16 | $444 | $28 |
| Amlodipine Besylate | 145 | $427 | $3 |
| Gabapentin | 52 | $390 | $7 |
| Isosorbide Mononitrate Er | 34 | $369 | $11 |
| Minoxidil | 23 | $306 | $13 |
| Furosemide | 125 | $284 | $2 |
| Tamsulosin | 25 | $279 | $11 |
| Midodrine | 14 | $275 | $20 |
| Klor-Con M20 | 24 | $260 | $11 |
| Pravastatin | 24 | $252 | $11 |
| Torsemide | 18 | $246 | $14 |
| Lisinopril | 59 | $227 | $4 |
| Simvastatin | 49 | $224 | $5 |
| Warfarin | 35 | $205 | $6 |
| Hydralazine | 23 | $204 | $9 |
| Metoprolol | 56 | $195 | $3 |
| Tramadol | 36 | $186 | $5 |
| Finasteride | 21 | $184 | $9 |
| Amlodipine Besylate-Benazepril | 12 | $178 | $15 |
| Escitalopram | 32 | $175 | $5 |
| Clopidogrel | 11 | $158 | $14 |
| Carvedilol | 33 | $154 | $5 |
| Irbesartan | 12 | $148 | $12 |
| Pantoprazole | 16 | $144 | $9 |
| Clonidine | 23 | $135 | $6 |
| Diltiazem 24hr Cd | 14 | $135 | $10 |
| Metformin | 23 | $124 | $5 |
| Tizanidine | 12 | $106 | $9 |
| Meloxicam | 26 | $98 | $4 |
| Montelukast | 13 | $94 | $7 |
| Promethazine | 16 | $81 | $5 |
| Metoclopramide | 15 | $80 | $5 |
| Spironolactone | 21 | $77 | $4 |
| Prednisone | 18 | $75 | $4 |
| Pioglitazone | 11 | $60 | $5 |
| Alendronate | 17 | $56 | $3 |
| Hydrochlorothiazide | 11 | $32 | $3 |
| Diazepam | 14 | $17 | $1 |
2015: 77 drugs
| Renvela | 131 | $263,761 | $2,013 |
| Sensipar | 133 | $195,283 | $1,468 |
| Procrit | 27 | $28,401 | $1,052 |
| Velphoro | 17 | $23,942 | $1,408 |
| Zetia | 66 | $17,545 | $266 |
| Paricalcitol | 36 | $8,400 | $233 |
| Januvia | 17 | $5,667 | $333 |
| Nexium | 17 | $4,223 | $248 |
| Bystolic | 43 | $4,112 | $96 |
| Lantus | 16 | $4,012 | $251 |
| Lyrica | 12 | $3,639 | $303 |
| Uloric | 12 | $3,019 | $252 |
| Vytorin | 12 | $2,725 | $227 |
| Colcrys | 16 | $2,157 | $135 |
| Doxazosin Mesylate | 65 | $1,996 | $31 |
| Nifedipine Er | 76 | $1,977 | $26 |
| Metoprolol | 60 | $1,960 | $33 |
| Diovan | 14 | $1,823 | $130 |
| Telmisartan | 21 | $1,762 | $84 |
| Megestrol Acetate | 23 | $1,714 | $75 |
| Duloxetine | 13 | $1,616 | $124 |
| Fenofibrate | 27 | $1,563 | $58 |
| Levothyroxine | 117 | $1,312 | $11 |
| Valsartan | 25 | $1,221 | $49 |
| Labetalol | 22 | $1,170 | $53 |
| Hydrocodone-Acetaminophen | 70 | $1,114 | $16 |
| Proair Hfa | 20 | $1,046 | $52 |
| Allopurinol | 71 | $831 | $12 |
| Calcitriol | 17 | $829 | $49 |
| Diltiazem Er | 13 | $786 | $60 |
| Amlodipine Besylate | 181 | $737 | $4 |
| Furosemide | 178 | $631 | $4 |
| Potassium Chloride | 29 | $580 | $20 |
| Pravastatin | 41 | $579 | $14 |
| Atorvastatin | 47 | $563 | $12 |
| Midodrine | 18 | $493 | $27 |
| Pioglitazone | 13 | $487 | $37 |
| Hydralazine | 50 | $484 | $10 |
| Isosorbide Mononitrate Er | 33 | $479 | $15 |
| Torsemide | 35 | $460 | $13 |
| Minoxidil | 36 | $432 | $12 |
| Gabapentin | 63 | $424 | $7 |
| Doxycycline Hyclate | 12 | $423 | $35 |
| Amlodipine Besylate-Benazepril | 19 | $394 | $21 |
| Metoprolol | 100 | $394 | $4 |
| Losartan | 79 | $356 | $5 |
| Simvastatin | 65 | $329 | $5 |
| Lisinopril | 68 | $295 | $4 |
| Tamsulosin | 21 | $282 | $13 |
| Tramadol | 55 | $253 | $5 |
| Escitalopram | 35 | $248 | $7 |
| Pantoprazole | 32 | $241 | $8 |
| Clopidogrel | 28 | $230 | $8 |
| Insulin | 13 | $224 | $17 |
| Clonidine | 35 | $217 | $6 |
| Warfarin | 36 | $213 | $6 |
| Metolazone | 14 | $199 | $14 |
| Meloxicam | 28 | $193 | $7 |
| Amoxicillin-Clavulanate Potass | 15 | $191 | $13 |
| Finasteride | 22 | $188 | $9 |
| Omeprazole | 25 | $187 | $7 |
| Zolpidem | 11 | $167 | $15 |
| Carvedilol | 25 | $166 | $7 |
| Glipizide | 27 | $147 | $5 |
| Spironolactone | 30 | $139 | $5 |
| Montelukast | 16 | $126 | $8 |
| Levofloxacin | 12 | $121 | $10 |
| Irbesartan-Hydrochlorothiazide | 12 | $119 | $10 |
| Tizanidine | 12 | $110 | $9 |
| Metformin | 31 | $109 | $4 |
| Metoclopramide | 21 | $90 | $4 |
| Clonazepam | 15 | $85 | $6 |
| Prednisone | 12 | $84 | $7 |
| Quinapril | 12 | $80 | $7 |
| Glyburide | 14 | $73 | $5 |
| Benazepril | 11 | $35 | $3 |
| Diazepam | 15 | $22 | $1 |
2014: 77 drugs
| Renvela | 196 | $350,138 | $1,786 |
| Sensipar | 146 | $170,539 | $1,168 |
| Procrit | 30 | $45,134 | $1,504 |
| Velphoro | 24 | $23,450 | $977 |
| Paricalcitol | 64 | $17,208 | $269 |
| Zetia | 63 | $13,574 | $215 |
| Januvia | 30 | $9,383 | $313 |
| Celebrex | 30 | $5,567 | $186 |
| Benicar | 34 | $5,479 | $161 |
| Spiriva | 16 | $4,678 | $292 |
| Zemplar | 15 | $4,662 | $311 |
| Lantus | 20 | $4,652 | $233 |
| Dexilant | 25 | $4,629 | $185 |
| Diovan | 28 | $4,488 | $160 |
| Bystolic | 49 | $4,122 | $84 |
| Nexium | 16 | $3,756 | $235 |
| Duloxetine | 17 | $2,748 | $162 |
| Fenofibrate | 28 | $2,741 | $98 |
| Telmisartan | 27 | $2,572 | $95 |
| Metoprolol | 48 | $2,223 | $46 |
| Colcrys | 17 | $2,177 | $128 |
| Doxazosin Mesylate | 66 | $2,098 | $32 |
| Labetalol | 24 | $2,076 | $86 |
| Premarin | 15 | $1,768 | $118 |
| Nifedipine Er | 36 | $1,591 | $44 |
| Hydrocodone-Acetaminophen | 110 | $1,078 | $10 |
| Levothyroxine | 98 | $1,047 | $11 |
| Torsemide | 43 | $1,018 | $24 |
| Synthroid | 33 | $962 | $29 |
| Atorvastatin | 46 | $804 | $17 |
| Furosemide | 166 | $777 | $5 |
| Pantoprazole | 64 | $774 | $12 |
| Amlodipine Besylate | 157 | $774 | $5 |
| Clonidine | 78 | $755 | $10 |
| Amlodipine Besylate-Benazepril | 21 | $754 | $36 |
| Hydralazine | 52 | $732 | $14 |
| Gabapentin | 56 | $647 | $12 |
| Clopidogrel | 47 | $619 | $13 |
| Pravastatin | 34 | $615 | $18 |
| Simvastatin | 89 | $607 | $7 |
| Diltiazem Er | 14 | $541 | $39 |
| Megestrol Acetate | 15 | $524 | $35 |
| Escitalopram | 37 | $516 | $14 |
| Potassium Chloride | 32 | $494 | $15 |
| Losartan | 56 | $480 | $9 |
| Allopurinol | 73 | $479 | $7 |
| Pioglitazone | 11 | $444 | $40 |
| Isosorbide Mononitrate Er | 35 | $419 | $12 |
| Metolazone | 24 | $415 | $17 |
| Tramadol | 52 | $379 | $7 |
| Nifedical Xl | 13 | $353 | $27 |
| Omeprazole | 34 | $325 | $10 |
| Carvedilol | 40 | $309 | $8 |
| Lisinopril | 65 | $265 | $4 |
| Montelukast | 13 | $263 | $20 |
| Glipizide | 55 | $247 | $4 |
| Metoprolol | 79 | $242 | $3 |
| Digox | 13 | $223 | $17 |
| Metformin | 42 | $219 | $5 |
| Finasteride | 15 | $214 | $14 |
| Risperidone | 18 | $200 | $11 |
| Insulin | 13 | $200 | $15 |
| Prednisone | 27 | $189 | $7 |
| Metoclopramide | 30 | $188 | $6 |
| Minoxidil | 16 | $186 | $12 |
| Tizanidine | 12 | $150 | $13 |
| Cefdinir | 11 | $147 | $13 |
| Warfarin | 26 | $134 | $5 |
| Tamsulosin | 13 | $134 | $10 |
| Quinapril | 12 | $82 | $7 |
| Zolpidem | 12 | $80 | $7 |
| Meloxicam | 18 | $76 | $4 |
| Levofloxacin | 11 | $59 | $5 |
| Glyburide | 11 | $45 | $4 |
| Clonazepam | 14 | $42 | $3 |
| Trazodone | 11 | $30 | $3 |
| Diazepam | 12 | $28 | $2 |
2013: 78 drugs
| Renvela | 221 | $329,397 | $1,490 |
| Sensipar | 112 | $106,934 | $955 |
| Zemplar | 53 | $16,453 | $310 |
| Januvia | 37 | $9,794 | $265 |
| Diovan | 60 | $8,394 | $140 |
| Sildenafil | 13 | $7,812 | $601 |
| Zetia | 39 | $6,906 | $177 |
| Nexium | 22 | $5,630 | $256 |
| Celebrex | 36 | $5,564 | $155 |
| Spiriva | 20 | $5,479 | $274 |
| Calcium Acetate | 21 | $4,284 | $204 |
| Benicar | 26 | $3,781 | $145 |
| Bystolic | 48 | $3,741 | $78 |
| Clopidogrel | 62 | $3,667 | $59 |
| Cymbalta | 19 | $3,575 | $188 |
| Colcrys | 21 | $3,352 | $160 |
| Micardis | 21 | $3,138 | $149 |
| Advair Diskus | 12 | $3,132 | $261 |
| Labetalol | 33 | $2,723 | $83 |
| Fenofibrate | 28 | $2,315 | $83 |
| Potassium Chloride | 53 | $2,130 | $40 |
| Nifedipine Er | 49 | $1,951 | $40 |
| Fentanyl | 15 | $1,699 | $113 |
| Atorvastatin | 63 | $1,429 | $23 |
| Lyrica | 14 | $1,385 | $99 |
| Hydrocodone-Acetaminophen | 152 | $1,241 | $8 |
| Prempro | 12 | $1,178 | $98 |
| Amlodipine Besylate | 156 | $1,006 | $6 |
| Levothyroxine | 145 | $996 | $7 |
| Pantoprazole | 61 | $993 | $16 |
| Synthroid | 30 | $885 | $29 |
| Clonidine | 86 | $875 | $10 |
| Metoprolol | 29 | $844 | $29 |
| Losartan-Hydrochlorothiazide | 13 | $831 | $64 |
| Simvastatin | 94 | $815 | $9 |
| Doxazosin Mesylate | 53 | $768 | $14 |
| Ramipril | 42 | $726 | $17 |
| Furosemide | 163 | $726 | $4 |
| Metoprolol | 124 | $701 | $6 |
| Escitalopram | 21 | $665 | $32 |
| Torsemide | 34 | $650 | $19 |
| Hydralazine | 40 | $606 | $15 |
| Gabapentin | 53 | $564 | $11 |
| Irbesartan-Hydrochlorothiazide | 11 | $554 | $50 |
| Carvedilol | 42 | $540 | $13 |
| Meloxicam | 45 | $456 | $10 |
| Isosorbide Dinitrate | 16 | $451 | $28 |
| Omeprazole | 26 | $429 | $17 |
| Montelukast | 15 | $411 | $27 |
| Warfarin | 53 | $395 | $7 |
| Tramadol | 40 | $351 | $9 |
| Allopurinol | 55 | $330 | $6 |
| Finasteride | 13 | $324 | $25 |
| Triamterene-Hctz | 20 | $321 | $16 |
| Cefdinir | 18 | $306 | $17 |
| Minoxidil | 14 | $283 | $20 |
| Lisinopril | 49 | $253 | $5 |
| Losartan | 22 | $249 | $11 |
| Metformin | 33 | $246 | $7 |
| Tamsulosin | 16 | $242 | $15 |
| Donepezil | 11 | $210 | $19 |
| Oxybutynin Chloride | 11 | $196 | $18 |
| Tizanidine | 11 | $195 | $18 |
| Clonazepam | 32 | $179 | $6 |
| Metolazone | 26 | $175 | $7 |
| Prednisone | 30 | $175 | $6 |
| Metoclopramide | 22 | $138 | $6 |
| Pravastatin | 13 | $120 | $9 |
| Promethazine | 17 | $114 | $7 |
| Glipizide | 21 | $114 | $5 |
| Hydrochlorothiazide | 20 | $111 | $6 |
| Amiodarone | 14 | $102 | $7 |
| Quinapril | 12 | $100 | $8 |
| Levofloxacin | 13 | $97 | $7 |
| Chlorthalidone | 11 | $91 | $8 |
| Isosorbide Mononitrate Er | 14 | $87 | $6 |
| Diazepam | 16 | $58 | $4 |
| Amitriptyline | 17 | $54 | $3 |
Money from drug and device companies
$145 in 2025
| 2025 | 6 | 12 | None | $145 |
| 2024 | 5 | 5 | None | $109 |
| 2023 | 1 | 1 | None | $21 |
| 2022 | 4 | 5 | None | $94 |
| 2021 | 2 | 4 | None | $72 |
| 2020 | 3 | 4 | None | $60 |
| 2019 | 4 | 9 | None | $156 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novo Nordisk | Rybelsus | $34 | 2 payments
|
| OPKO Pharmaceuticals | Rayaldee | $31 | 2 payments
|
| Travere Therapeutics | Filspari | $29 | 5 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $18 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $17 | 1 payment
|
| Amgen | Tavneos | $15 | 1 payment
|
See all 12 published payments
| Travere Therapeutics | Education · 2025-12-15 | Filspari | $0 |
| Novo Nordisk | Meals · 2025-10-28 | Rybelsus | $19 |
| Travere Therapeutics | Meals · 2025-09-17 | Filspari | $11 |
| Novo Nordisk | Meals · 2025-08-28 | Rybelsus | $15 |
| OPKO Pharmaceuticals | Education · 2025-08-13 | Rayaldee | $15 |
| Travere Therapeutics | Meals · 2025-08-12 | None | $15 |
| Amgen | Meals · 2025-07-09 | Tavneos | $15 |
| Travere Therapeutics | Education · 2025-05-12 | Filspari | $2 |
| Travere Therapeutics | Education · 2025-04-23 | Filspari | $2 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-04-21 | Kerendia | $17 |
| OPKO Pharmaceuticals | Education · 2025-03-16 | Rayaldee | $16 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-03-11 | Jardiance | $18 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $109
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $26 | 1 payment
|
| Fresenius USA Marketing | Velphoro | $24 | 1 payment
|
| Mallinckrodt Hospital Products | Acthar | $22 | 1 payment
|
| Amgen | Tavneos | $21 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $16 | 1 payment
|
2023: $21
| OPKO Pharmaceuticals | Rayaldee | $21 | 1 payment
|
2022: $94
| Vifor Pharma | Veltassa | $42 | 2 payments
|
| Medtronic | Ellipsys Vascular Access System | $22 | 1 payment
|
| Argon Medical Devices | Thrombectomy | $16 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $14 | 1 payment
|
2021: $72
| Fresenius USA Marketing | Velphoro | $39 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $32 | 2 payments
|
2020: $60
| Otsuka America Pharmaceutical | Jynarque | $28 | 2 payments
|
| GlaxoSmithKline | Benlysta | $20 | 1 payment
|
| Fresenius USA Marketing | Velphoro | $12 | 1 payment
|
2019: $156
| Amgen | Parsabiv | $107 | 6 payments
|
| Shire North American Group | Gattex | $19 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $17 | 1 payment
|
| OPKO Pharmaceuticals | Rayaldee | $14 | 1 payment
|
Checkups this office reported
14 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 79.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 76%That's most of the people this applied to. | 125 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 56%That's more than half. | 34 |
| Breast cancer screeningEligible women who got a mammogram | 0%That's few of the people this applied to. | 46 |
| Cervical cancer screeningEligible women who got a Pap or HPV test | 0%That's few of the people this applied to. | 20 |
| Checked for fall riskOlder patients screened for fall risk | 97%That's most of the people this applied to. | 143 |
| Colon cancer screeningEligible adults who got a colon cancer test | 0%That's few of the people this applied to. | 116 |
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 0%That's few of the people this applied to. | 201 |
| Diabetes eye examPeople with diabetes who got a retinal eye exam | 0%That's few of the people this applied to. | 53 |
See the other 6 measures
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 96%That's most of the people this applied to. Worse on this measure. | 53 |
| Medications listed in the chartVisits where the current medication list was documented | 99%That's most of the people this applied to. | 399 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 2%That's few of the people this applied to. Better on this measure. | 151 |
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 18% | 84 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 34%That's less than half. | 74 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 98%That's most of the people this applied to. | 200 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Collects patient feedback
- Implementation of fall screening and assessment programs
- Participate in IHI Training/Forum Event; National Academy of Medicine, AHRQ Team STEPPS or Other Similar Activity
- Uses standard treatment protocols
Professional record
- NPI
- 1417927492
- Licence
- LA 021439
- Trained
- Tulane University School of Medicine, 1991 · 35 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- LA 1670146
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 711 Wood St, Ste A, Monroe, LA, 71201
- NPI first listed
- 2006-01-24
- NPI last updated
- 2009-12-03
This is when the NPI record was last certified, not a medical board exam.